Main Content

Published Before Print

Imaging Techniques in the Diagnosis of Renal Cell Carcinoma: Contemporary Trends and Future Directions

Increasing radiographic detection of incidental small renal masses has led to a growing concern regarding overtreatment of these lesions. Given the limitations of computed tomography and magnetic resonance imaging, there is an unmet need for improved kidney imaging techniques that can provide more accurate assessments of renal lesions. This review provides a summary of established kidney imaging modalities and also those likely to be meaningful in the near future. Kidney imaging has evolved, with several modalities contributing to the overall diagnostic landscape. There is great optimism that a new era of molecular imaging in renal cell carcinoma can vastly improve diagnostic capabilities and limit unnecessary invasive procedures.

Gautam Jayram, MD

About the Journal

Reviews in Urology first launched in 1999 as a PubMed-indexed, quarterly journal featuring peer-reviewed research, case studies, thought leader interviews, and insights on emerging trends and research shaping the field of urology. New publisher, Specialty Networks, now plans to build on the journal’s long-standing focus on cutting-edge urology advances while offering expanded coverage of a broad range of urologic conditions and specialty care concerns.

Reviews in Urology, Specialty Networks’ flagship publication and the official journal of LUGPA, is designed to review the latest advances in the diagnosis and treatment of a wide range of urological conditions to help the busy, practicing urologist keep up to date with the rapidly evolving field of urology.

Reviews in Urology circulation is approximately all 10,000+ practicing urologists, including residents and fellows, in the United States.

RIU Mobile

View our mobile app for the best experience on your mobile device.

Download on the Apple app storeDownload on the Apple app store
Submit your Manuscript

Interested in submitting your manuscript for consideration?

Advertise in RIU

Want to reach a wider audience through the journal?

From the Journal

View articles from the latest issues.

Letter From the President of LUGPA

Evan R Goldfischer

As we approach the next election, it is of utmost importance that we, as one of the strongest voices for independent medicine, engage in political advocacy. Our mission is to ensure that the independent practice of urology endures while showcasing outstanding quality and value to our patients, vendors, payers, legislators, and regulatory agencies. To achieve this, we must actively preserve our autonomy and demonstrate the highest quality standards through evidence-based practices and effective communication.

An interview with Shailendra Sharma, CEO, Specialty Networks

Neal D Shore

The LUGPA board, in partnership with Specialty Networks, was thrilled to announce the return of Reviews in Urology in 2024, and no one more so than Specialty Networks’ CEO, Shailendra Sharma. “We are honored for our Reviews in Urology publication to be designated as the official journal of LUGPA and to further strengthen our partnership and commitment to LUGPA’s mission of preserving and advancing the independent practice of urology,” he said. Reviews in Urology first launched in 1999 as a PubMed-indexed, quarterly journal featuring peer-reviewed research, case studies, thought leader interviews, and insights on emerging trends and research shaping the field of urology. Mr Sharma says that Specialty Networks now plans to build on the journal’s long-standing focus on cutting-edge urology advances while offering expanded coverage of a broad range of urologic conditions and specialty care concerns. Mr Sharma sat down to talk with Neal Shore, MD, editor in chief of Reviews in Urology, to discuss the journal’s history and his hopes for the future of the journal and the profession.